APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihemorrhagic Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antihemorrhagic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchAntihemorrhagic Agent Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihemorrhagic Agent Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Antihemorrhagic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihemorrhagic Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihemorrhagic Agent Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antihemorrhagic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antihemorrhagic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihemorrhagic Agent include Biocer, C. R. Bard (BD), Celox, Equimedical, Ethicon, Gelita Medical, Hemostasis, Hemotec Medical and MBP, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antihemorrhagic Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antihemorrhagic Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antihemorrhagic Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antihemorrhagic Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Antihemorrhagic Agent Segment by Company

Biocer

C. R. Bard (BD)

Celox

Equimedical

Ethicon

Gelita Medical

Hemostasis

Hemotec Medical

MBP

Medira

Starch Medical

Pfizer

Success Pharmaceutical

Changsha Hairun

Antihemorrhagic Agent Segment by Type

Microfibrillar Collagen

Chitosan

Other

Antihemorrhagic Agent Segment by Application

Surgical Wound Care

General Wound Care

Antihemorrhagic Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihemorrhagic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihemorrhagic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihemorrhagic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antihemorrhagic Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihemorrhagic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antihemorrhagic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antihemorrhagic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antihemorrhagic Agent Industry Trends Table 2. Antihemorrhagic Agent Industry Drivers Table 3. Antihemorrhagic Agent Industry Opportunities and Challenges Table 4. Antihemorrhagic Agent Industry Restraints Table 5. Global Antihemorrhagic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antihemorrhagic Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antihemorrhagic Agent Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Antihemorrhagic Agent Sales Market Share by Manufacturers Table 9. Global Antihemorrhagic Agent Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Antihemorrhagic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antihemorrhagic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antihemorrhagic Agent Manufacturers, Product Type & Application Table 13. Global Antihemorrhagic Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antihemorrhagic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Microfibrillar Collagen Table 17. Major Manufacturers of Chitosan Table 18. Major Manufacturers of Other Table 19. Global Antihemorrhagic Agent Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Antihemorrhagic Agent Sales by Type (2021-2026) & (k units) Table 21. Global Antihemorrhagic Agent Sales by Type (2027-2032) & (k units) Table 22. Global Antihemorrhagic Agent Sales Market Share by Type (2021-2026) Table 23. Global Antihemorrhagic Agent Sales Market Share by Type (2027-2032) Table 24. Global Antihemorrhagic Agent Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Antihemorrhagic Agent Revenue by Type (2021-2026) & (k units) Table 26. Global Antihemorrhagic Agent Revenue by Type (2027-2032) & (k units) Table 27. Global Antihemorrhagic Agent Revenue Market Share by Type (2021-2026) Table 28. Global Antihemorrhagic Agent Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Surgical Wound Care Table 30. Major Manufacturers of General Wound Care Table 31. Global Antihemorrhagic Agent Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Antihemorrhagic Agent Sales by Application (2021-2026) & (k units) Table 33. Global Antihemorrhagic Agent Sales by Application (2027-2032) & (k units) Table 34. Global Antihemorrhagic Agent Sales Market Share by Application (2021-2026) Table 35. Global Antihemorrhagic Agent Sales Market Share by Application (2027-2032) Table 36. Global Antihemorrhagic Agent Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Antihemorrhagic Agent Revenue by Application (2021-2026) & (k units) Table 38. Global Antihemorrhagic Agent Revenue by Application (2027-2032) & (k units) Table 39. Global Antihemorrhagic Agent Revenue Market Share by Application (2021-2026) Table 40. Global Antihemorrhagic Agent Revenue Market Share by Application (2027-2032) Table 41. Global Antihemorrhagic Agent Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Antihemorrhagic Agent Sales by Region (2021-2026) & (k units) Table 43. Global Antihemorrhagic Agent Sales Market Share by Region (2021-2026) Table 44. Global Antihemorrhagic Agent Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Antihemorrhagic Agent Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 48. North America Antihemorrhagic Agent Sales by Country (2027-2032) & (k units) Table 49. Europe Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 51. Europe Antihemorrhagic Agent Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Antihemorrhagic Agent Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Antihemorrhagic Agent Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Antihemorrhagic Agent Sales by Country (2027-2032) & (k units) Table 58. Global Antihemorrhagic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antihemorrhagic Agent Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Antihemorrhagic Agent Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Antihemorrhagic Agent Revenue Market Share by Region (2021-2026) Table 62. Global Antihemorrhagic Agent Revenue Market Share by Region (2027-2032) Table 63. Biocer Company Information Table 64. Biocer Business Overview Table 65. Biocer Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biocer Antihemorrhagic Agent Product Portfolio Table 67. Biocer Recent Development Table 68. C. R. Bard (BD) Company Information Table 69. C. R. Bard (BD) Business Overview Table 70. C. R. Bard (BD) Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. C. R. Bard (BD) Antihemorrhagic Agent Product Portfolio Table 72. C. R. Bard (BD) Recent Development Table 73. Celox Company Information Table 74. Celox Business Overview Table 75. Celox Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Celox Antihemorrhagic Agent Product Portfolio Table 77. Celox Recent Development Table 78. Equimedical Company Information Table 79. Equimedical Business Overview Table 80. Equimedical Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Equimedical Antihemorrhagic Agent Product Portfolio Table 82. Equimedical Recent Development Table 83. Ethicon Company Information Table 84. Ethicon Business Overview Table 85. Ethicon Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Ethicon Antihemorrhagic Agent Product Portfolio Table 87. Ethicon Recent Development Table 88. Gelita Medical Company Information Table 89. Gelita Medical Business Overview Table 90. Gelita Medical Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Gelita Medical Antihemorrhagic Agent Product Portfolio Table 92. Gelita Medical Recent Development Table 93. Hemostasis Company Information Table 94. Hemostasis Business Overview Table 95. Hemostasis Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hemostasis Antihemorrhagic Agent Product Portfolio Table 97. Hemostasis Recent Development Table 98. Hemotec Medical Company Information Table 99. Hemotec Medical Business Overview Table 100. Hemotec Medical Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Hemotec Medical Antihemorrhagic Agent Product Portfolio Table 102. Hemotec Medical Recent Development Table 103. MBP Company Information Table 104. MBP Business Overview Table 105. MBP Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. MBP Antihemorrhagic Agent Product Portfolio Table 107. MBP Recent Development Table 108. Medira Company Information Table 109. Medira Business Overview Table 110. Medira Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Medira Antihemorrhagic Agent Product Portfolio Table 112. Medira Recent Development Table 113. Starch Medical Company Information Table 114. Starch Medical Business Overview Table 115. Starch Medical Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Starch Medical Antihemorrhagic Agent Product Portfolio Table 117. Starch Medical Recent Development Table 118. Pfizer Company Information Table 119. Pfizer Business Overview Table 120. Pfizer Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Pfizer Antihemorrhagic Agent Product Portfolio Table 122. Pfizer Recent Development Table 123. Success Pharmaceutical Company Information Table 124. Success Pharmaceutical Business Overview Table 125. Success Pharmaceutical Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Success Pharmaceutical Antihemorrhagic Agent Product Portfolio Table 127. Success Pharmaceutical Recent Development Table 128. Changsha Hairun Company Information Table 129. Changsha Hairun Business Overview Table 130. Changsha Hairun Antihemorrhagic Agent Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Changsha Hairun Antihemorrhagic Agent Product Portfolio Table 132. Changsha Hairun Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Antihemorrhagic Agent Distributors List Table 136. Antihemorrhagic Agent Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Antihemorrhagic Agent Product Image Figure 2. Global Antihemorrhagic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihemorrhagic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihemorrhagic Agent Sales (2021-2032) & (k units) Figure 5. Global Antihemorrhagic Agent Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antihemorrhagic Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Microfibrillar Collagen Image Figure 9. Chitosan Image Figure 10. Other Image Figure 11. Global Antihemorrhagic Agent Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Antihemorrhagic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Antihemorrhagic Agent Sales Market Share by Type (2021-2032) Figure 14. Global Antihemorrhagic Agent Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Antihemorrhagic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antihemorrhagic Agent Revenue Market Share by Type (2021-2032) Figure 17. Surgical Wound Care Image Figure 18. General Wound Care Image Figure 19. Global Antihemorrhagic Agent Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Antihemorrhagic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antihemorrhagic Agent Sales Market Share by Application (2021-2032) Figure 22. Global Antihemorrhagic Agent Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Antihemorrhagic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antihemorrhagic Agent Revenue Market Share by Application (2021-2032) Figure 25. North America Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Antihemorrhagic Agent Sales Market Share by Country (2021-2032) Figure 27. U.S. Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Antihemorrhagic Agent Sales Market Share by Country (2021-2032) Figure 32. Germany Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Antihemorrhagic Agent Sales Market Share by Country (2021-2032) Figure 39. China Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Antihemorrhagic Agent Sales Market Share by Country (2021-2032) Figure 47. Brazil Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Antihemorrhagic Agent Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Antihemorrhagic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Antihemorrhagic Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Antihemorrhagic Agent Revenue (2021-2032) & (US$ Million) Figure 58. North America Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antihemorrhagic Agent Revenue (2021-2032) & (US$ Million) Figure 60. Europe Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antihemorrhagic Agent Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Antihemorrhagic Agent Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antihemorrhagic Agent Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Antihemorrhagic Agent Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Microfibrillar Collagen
  • Chitosan
  • Other
Applications
  • Surgical Wound Care
  • General Wound Care
Companies covered
  • Biocer
  • C. R. Bard (BD)
  • Celox
  • Equimedical
  • Ethicon
  • Gelita Medical
  • Hemostasis
  • Hemotec Medical
  • MBP
  • Medira
  • Starch Medical
  • Pfizer
  • Success Pharmaceutical
  • Changsha Hairun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antihemorrhagic Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antihemorrhagic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antihemorrhagic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antihemorrhagic Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antihemorrhagic Agent Market Dynamics
  1. 2.1 Antihemorrhagic Agent Industry Trends
  2. 2.2 Antihemorrhagic Agent Industry Drivers
  3. 2.3 Antihemorrhagic Agent Industry Opportunities and Challenges
  4. 2.4 Antihemorrhagic Agent Industry Restraints
3 Antihemorrhagic Agent Market by Manufacturers
  1. 3.1 Global Antihemorrhagic Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antihemorrhagic Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antihemorrhagic Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antihemorrhagic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihemorrhagic Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antihemorrhagic Agent Manufacturers, Product Type & Application
  7. 3.7 Global Antihemorrhagic Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihemorrhagic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihemorrhagic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihemorrhagic Agent Tier 1, Tier 2, and Tier 3
4 Antihemorrhagic Agent Market by Type
  1. 4.1 Antihemorrhagic Agent Type Introduction
  2. 4.1.1 Microfibrillar Collagen
  3. 4.1.2 Chitosan
  4. 4.1.3 Other
  5. 4.2 Global Antihemorrhagic Agent Sales by Type
  6. 4.2.1 Global Antihemorrhagic Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antihemorrhagic Agent Sales by Type (2021-2032)
  8. 4.2.3 Global Antihemorrhagic Agent Sales Market Share by Type (2021-2032)
  9. 4.3 Global Antihemorrhagic Agent Revenue by Type
  10. 4.3.1 Global Antihemorrhagic Agent Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antihemorrhagic Agent Revenue by Type (2021-2032)
  12. 4.3.3 Global Antihemorrhagic Agent Revenue Market Share by Type (2021-2032)
5 Antihemorrhagic Agent Market by Application
  1. 5.1 Antihemorrhagic Agent Application Introduction
  2. 5.1.1 Surgical Wound Care
  3. 5.1.2 General Wound Care
  4. 5.2 Global Antihemorrhagic Agent Sales by Application
  5. 5.2.1 Global Antihemorrhagic Agent Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antihemorrhagic Agent Sales by Application (2021-2032)
  7. 5.2.3 Global Antihemorrhagic Agent Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antihemorrhagic Agent Revenue by Application
  9. 5.3.1 Global Antihemorrhagic Agent Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antihemorrhagic Agent Revenue by Application (2021-2032)
  11. 5.3.3 Global Antihemorrhagic Agent Revenue Market Share by Application (2021-2032)
6 Global Antihemorrhagic Agent Sales by Region
  1. 6.1 Global Antihemorrhagic Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antihemorrhagic Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Antihemorrhagic Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Antihemorrhagic Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antihemorrhagic Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antihemorrhagic Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antihemorrhagic Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antihemorrhagic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antihemorrhagic Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antihemorrhagic Agent Revenue by Region
  1. 7.1 Global Antihemorrhagic Agent Revenue by Region
  2. 7.1.1 Global Antihemorrhagic Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antihemorrhagic Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Antihemorrhagic Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Antihemorrhagic Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antihemorrhagic Agent Revenue (2021-2032)
  8. 7.2.2 North America Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antihemorrhagic Agent Revenue (2021-2032)
  11. 7.3.2 Europe Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antihemorrhagic Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antihemorrhagic Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antihemorrhagic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biocer
  2. 8.1.1 Biocer Company Information
  3. 8.1.2 Biocer Business Overview
  4. 8.1.3 Biocer Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biocer Antihemorrhagic Agent Product Portfolio
  6. 8.1.5 Biocer Recent Developments
  7. 8.2 C. R. Bard (BD)
  8. 8.2.1 C. R. Bard (BD) Company Information
  9. 8.2.2 C. R. Bard (BD) Business Overview
  10. 8.2.3 C. R. Bard (BD) Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 C. R. Bard (BD) Antihemorrhagic Agent Product Portfolio
  12. 8.2.5 C. R. Bard (BD) Recent Developments
  13. 8.3 Celox
  14. 8.3.1 Celox Company Information
  15. 8.3.2 Celox Business Overview
  16. 8.3.3 Celox Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Celox Antihemorrhagic Agent Product Portfolio
  18. 8.3.5 Celox Recent Developments
  19. 8.4 Equimedical
  20. 8.4.1 Equimedical Company Information
  21. 8.4.2 Equimedical Business Overview
  22. 8.4.3 Equimedical Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Equimedical Antihemorrhagic Agent Product Portfolio
  24. 8.4.5 Equimedical Recent Developments
  25. 8.5 Ethicon
  26. 8.5.1 Ethicon Company Information
  27. 8.5.2 Ethicon Business Overview
  28. 8.5.3 Ethicon Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ethicon Antihemorrhagic Agent Product Portfolio
  30. 8.5.5 Ethicon Recent Developments
  31. 8.6 Gelita Medical
  32. 8.6.1 Gelita Medical Company Information
  33. 8.6.2 Gelita Medical Business Overview
  34. 8.6.3 Gelita Medical Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Gelita Medical Antihemorrhagic Agent Product Portfolio
  36. 8.6.5 Gelita Medical Recent Developments
  37. 8.7 Hemostasis
  38. 8.7.1 Hemostasis Company Information
  39. 8.7.2 Hemostasis Business Overview
  40. 8.7.3 Hemostasis Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hemostasis Antihemorrhagic Agent Product Portfolio
  42. 8.7.5 Hemostasis Recent Developments
  43. 8.8 Hemotec Medical
  44. 8.8.1 Hemotec Medical Company Information
  45. 8.8.2 Hemotec Medical Business Overview
  46. 8.8.3 Hemotec Medical Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hemotec Medical Antihemorrhagic Agent Product Portfolio
  48. 8.8.5 Hemotec Medical Recent Developments
  49. 8.9 MBP
  50. 8.9.1 MBP Company Information
  51. 8.9.2 MBP Business Overview
  52. 8.9.3 MBP Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MBP Antihemorrhagic Agent Product Portfolio
  54. 8.9.5 MBP Recent Developments
  55. 8.10 Medira
  56. 8.10.1 Medira Company Information
  57. 8.10.2 Medira Business Overview
  58. 8.10.3 Medira Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medira Antihemorrhagic Agent Product Portfolio
  60. 8.10.5 Medira Recent Developments
  61. 8.11 Starch Medical
  62. 8.11.1 Starch Medical Company Information
  63. 8.11.2 Starch Medical Business Overview
  64. 8.11.3 Starch Medical Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Starch Medical Antihemorrhagic Agent Product Portfolio
  66. 8.11.5 Starch Medical Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Antihemorrhagic Agent Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Success Pharmaceutical
  74. 8.13.1 Success Pharmaceutical Company Information
  75. 8.13.2 Success Pharmaceutical Business Overview
  76. 8.13.3 Success Pharmaceutical Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Success Pharmaceutical Antihemorrhagic Agent Product Portfolio
  78. 8.13.5 Success Pharmaceutical Recent Developments
  79. 8.14 Changsha Hairun
  80. 8.14.1 Changsha Hairun Company Information
  81. 8.14.2 Changsha Hairun Business Overview
  82. 8.14.3 Changsha Hairun Antihemorrhagic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Changsha Hairun Antihemorrhagic Agent Product Portfolio
  84. 8.14.5 Changsha Hairun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antihemorrhagic Agent Value Chain Analysis
  2. 9.1.1 Antihemorrhagic Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antihemorrhagic Agent Production Mode & Process
  6. 9.2 Antihemorrhagic Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antihemorrhagic Agent Distributors
  9. 9.2.3 Antihemorrhagic Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst